rocky start for alzheimers research
Last Updated : GMT 12:24:11
Arab Today, arab today
Arab Today, arab today

in 2018

Rocky start for Alzheimer's research

Arab Today, arab today

Arab Today, arab today Rocky start for Alzheimer's research

Designer Guio Di Colombia in Inclusion fashion show in Colombia.
Paris - Arab Today

The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Within the first three weeks, pharmaceutical giant Pfizer abandoned the costly and frustrating field of dementia drug development, and two promising treatments stumbled in patient trials.

Alzheimer's support groups are putting on a brave face, but the collective disappointment is palpable as the global cost of caring for some 50 million dementia sufferers is set to reach $1 trillion (819 billion euros) this year.

"It's very fair to say that progress is slow," David Reynolds, chief scientific officer at Alzheimer's Research UK, a charity, told AFP.

"Companies have put a lot of time, effort and money in over the last 25 years, and there haven't been any new medicines launched in this area for 16 years now."

Experts say it takes 12–15 years, on average, and more than $2 billion to develop a single drug.

According to the Alzforum website, which gathers data on candidate drugs, fewer than 300 have made it to Phase II drug efficiency trials so far.

Only five have ever been approved to treat symptoms such as memory loss associated with Alzheimer's, first identified more than 100 years ago.

With a clinical trial failure rate of over 99 percent, there is still no licenced drug that slows the condition's progression, or cures it.

Today, about 100 candidate dementia drugs are enrolled in trials, compared to over 1,000 for cancer, according to Reynolds.

One reason is that "pharmaceutical companies ultimately are companies. They are beholden to their investors," he said.

"A return on investment is really: How much time and money do you put into getting a new medicine versus how much money can you make once you've actually got it? In this area, success has been very difficult to come by."

- Mysterious brain -

The stakes are high.

According to the World Health Organization (WHO), some 10 million people per year are diagnosed with dementia, with Alzheimer's disease accounting for about two-thirds of cases.

By 2030, the number of sufferers is projected to reach 82 million globally, and by 2050 some 152 million.

The medical, patient-care, and economic costs are enormous.

A heavy burden falls on family members, the majority of care providers worldwide. Many have to give up their jobs.

Alzheimer's affects mainly older people -- about one in four over-85s is a sufferer. And numbers have soared as lifespans have lengthened thanks to medical advances in other fields.

With cardiovascular disease and cancer the biggest killers in the 1960s and '70s, that is where most of the research money went.

"In dementia, that investment wasn't there. So the amount of knowledge... about the disease is at a much, much earlier stage, and arguably the brain is a much more complicated organ" than the heart, said Reynolds.

To this day, scientists don't know exactly what causes Alzheimer's, leaving drug developers stumped.

On January 6, Pfizer announced an end to its "discovery and early development efforts" for Alzheimer's and Parkinson's dementia drugs.

Two days later, Danish company Lundbeck reported its idalopirdine compound did not "decrease cognitive loss" in patients, and on January 12, biotech firm Axovant announced the end of the road for its offering, intepirdine.

- Slow, but not backwards -

Experts say every failure of a drug reveals something new about Alzheimer's disease, which is thought to be associated with a buildup of protein "plaques", and "tangles" in the brain.

One important recent realisation was that an effective treatment may have to begin long before symptoms appear as protein build-up likely starts decades before disease sets in.

This, in itself, presents a research challenge.

"How do you find these patients?" when they are in middle age and symptom-free, explained French neurology professor Bruno Dubois. "How long do you treat them?"

Drugs in development today are targeting several tracks.

Some use antibodies to mop up proteins in circulation, or enzymes to inhibit their production.

Another experimental approach is vaccination: training the body to produce its own antibodies to attack disease-causing proteins.

"We are not moving backwards," insisted Reynolds.

Yet, he was "by no means certain" that a goal set by the G8 in 2013 to develop a cure or treatment for dementia by 2025 can be met.

"Even knowing the obstacles, we have never been as optimistic as we are today," added James Hendrix, a director at the US-based Alzheimer's Association, one of several non-profit research funders.

"We will not slow down in our fight against this terrible disease," he vowed.

"We are steadfastly committed to both advocating for further increased federal funding for Alzheimer's and dementia research, and increasing our own level of research funding to get us to where we ultimately need to be -- a world without Alzheimer's disease."

Source: AFP

 

arabstoday
arabstoday

GMT 08:10 2018 Tuesday ,23 January

To 'eternal style' of late Alaia

GMT 03:13 2018 Thursday ,18 January

designer Jones quits Louis Vuitton

GMT 04:26 2018 Wednesday ,17 January

Pretty dresses are no longer just

GMT 03:28 2018 Tuesday ,09 January

Dior Paris fashion exhibition breaks

GMT 07:58 2017 Tuesday ,19 December

Legend Alaia's last designs
Arab Today, arab today
Arab Today, arab today

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

rocky start for alzheimers research rocky start for alzheimers research

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

rocky start for alzheimers research rocky start for alzheimers research

 



Arab Today, arab today
Arab Today, arab today Skincare PR Performance Full Year 2017

GMT 10:35 2018 Monday ,22 January

Skincare PR Performance Full Year 2017
Arab Today, arab today New hunt for flight MH370 gets under way

GMT 02:36 2018 Wednesday ,24 January

New hunt for flight MH370 gets under way
Arab Today, arab today Modern colorful bedroom renovation

GMT 11:23 2017 Thursday ,21 December

Modern colorful bedroom renovation
Arab Today, arab today France sanctions businesses linked

GMT 01:58 2018 Wednesday ,24 January

France sanctions businesses linked
Arab Today, arab today Turkey detains dozens more

GMT 02:09 2018 Wednesday ,24 January

Turkey detains dozens more
Arab Today, arab today The Rake announces editorial updates

GMT 12:19 2018 Tuesday ,16 January

The Rake announces editorial updates
Arab Today, arab today Europe brings on charm and blue skies

GMT 06:12 2018 Tuesday ,23 January

Europe brings on charm and blue skies
Arab Today, arab today For the Variety of Interior Design Styles

GMT 11:14 2017 Tuesday ,19 December

For the Variety of Interior Design Styles
Arab Today, arab today Puigdemont candidate for Catalan president

GMT 05:31 2018 Tuesday ,23 January

Puigdemont candidate for Catalan president
Arab Today, arab today Amazon to open first cashierless shop

GMT 05:52 2018 Tuesday ,23 January

Amazon to open first cashierless shop

GMT 13:36 2017 Friday ,22 December

Iraqi troops killed six ISIS militants in Mousl

GMT 12:33 2017 Friday ,22 December

Yara denies presenting new talk show

GMT 01:00 2017 Wednesday ,20 December

Saudi and Russia expnad food integration

GMT 14:33 2017 Tuesday ,19 December

German business morale eases back from record high

GMT 12:32 2017 Tuesday ,19 December

UK weather: The latest Sky News forecast

GMT 04:53 2017 Tuesday ,19 December

Egypt’s government signs agreement with Switzerland

GMT 04:27 2017 Tuesday ,19 December

Tensions dominate the Iranian parliament amid fears

GMT 11:35 2017 Monday ,18 December

Putin appreciates U.S intelligence cooperation

GMT 08:05 2017 Monday ,18 December

Mona Zaki reveals details of her new show

GMT 17:32 2017 Sunday ,17 December

Polls open in Chilean presidential election

GMT 07:16 2017 Sunday ,17 December

Yasmine Underlines importance of Fatimid Cairo

GMT 20:34 2018 Saturday ,20 January

Bahrain press headlines

GMT 22:38 2018 Tuesday ,23 January

Bahrain Press headlines

GMT 07:22 2017 Thursday ,23 November

Zimbabwe's next leader heads home after Mugabe exit

GMT 07:23 2017 Thursday ,23 November

Zimbabwe's next leader heads home after Mugabe exit

GMT 16:25 2016 Thursday ,22 December

Italian bank Monte Paschi edges closer to state bailout

GMT 06:41 2018 Saturday ,17 March

testing from boss1

GMT 09:12 2017 Friday ,17 November

Gleam Futures represents Grace Beverley

GMT 06:03 2014 Wednesday ,09 April

Please .. Let Gaza breathe!

GMT 08:10 2018 Tuesday ,23 January

To 'eternal style' of late Alaia

GMT 16:03 2017 Thursday ,21 December

US hits Myanmar general in new global rights sanctions

GMT 16:33 2014 Thursday ,13 November

Al-Ehtimam Bil Aakhareen
Arab Today, arab today
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube
arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday